Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191378
Max Phase: Preclinical
Molecular Formula: C42H60N8O9S2
Molecular Weight: 885.12
Associated Items:
ID: ALA5191378
Max Phase: Preclinical
Molecular Formula: C42H60N8O9S2
Molecular Weight: 885.12
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2)CSCc2cccc(n2)CSC[C@@H](C(=O)O)NC(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C42H60N8O9S2/c1-23(2)16-31-38(54)44-25(5)36(52)50-35(42(58)59)22-61-20-28-9-6-8-27(45-28)19-60-21-34(49-37(53)30-10-7-15-43-30)41(57)47-32(17-24(3)4)39(55)48-33(40(56)46-31)18-26-11-13-29(51)14-12-26/h6,8-9,11-14,23-25,30-35,43,51H,7,10,15-22H2,1-5H3,(H,44,54)(H,46,56)(H,47,57)(H,48,55)(H,49,53)(H,50,52)(H,58,59)/t25-,30-,31-,32-,33-,34-,35-/m0/s1
Standard InChI Key: METYKGYVFSESFD-PTQLHCGHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 885.12 | Molecular Weight (Monoisotopic): 884.3925 | AlogP: 1.37 | #Rotatable Bonds: 9 |
Polar Surface Area: 257.05 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.54 | CX Basic pKa: 9.80 | CX LogP: -1.26 | CX LogD: -1.26 |
Aromatic Rings: 2 | Heavy Atoms: 61 | QED Weighted: 0.17 | Np Likeness Score: 0.68 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):